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A B S T R A C T
Exosomes, a type of extracellular vesicles, can be collected from the conditioned medium of cultured cells, and
are expected to be used in disease therapy and drug delivery systems. However, since the yield of exosomes from
conditioned medium is generally low, investigations to develop new methods to increase exosome secretion and
to elucidate the secretion mechanism have been performed. Our previous studies demonstrated that activation of
intracellular signaling including Rho GTPase and subsequent endocytosis of extraneous molecules in cells could
be induced by low level electricity (0.3–0.5 mA/cm2). Since exosomes are produced in the process of endocytosis
and secreted by exocytosis via certain signaling pathways, we hypothesized that low level electric treatment (ET)
would increase exosome secretion from cultured cells via intracellular signaling activation. In the present study,
the influence of ET (0.34 mA/cm2) on extracellular vesicle (EV) secretion from cultured cells was examined by
using murine melanoma and murine fibroblast cells. The results showed that the number of EV particles col-
lected by ultracentrifugation was remarkably increased by ET in both cell lines without cellular toxicity or
changes in the particle distribution. Also, protein amounts of the collected EVs were significantly increased in
both cells by ET without alteration of expression of representative exosome marker proteins. Moreover, in both
cells, the ratio of particle numbers to protein amount was not significantly changed by ET. Rho GTPase inhibition
significantly suppressed ET-mediated increase of EV secretion in murine melanoma, indicating that Rho GTPase
activation could be involved in ET-mediated EV secretion in the cell. Additionally, there were almost no dif-
ferences in uptake of each EV into each donor cell regardless of whether the cells had been exposed to ET for EV
collection. Taken together, these results suggest that ET could increase EV secretion from both cancer and
normal cells without apparent changes in EV quality.
1. Introduction
Exosomes, a type of extracellular vesicle (EV), are composed of lipid
bilayers, characteristically with diameters of 40–150 nm; they are se-
creted by a variety of cell types [1]. Exosomes are involved in inter-
cellular communication via delivery of proteins and nucleic acids, in-
cluding microRNA (miRNA) and mRNA [2]. Since exosomes can
transport endogenous cargo (proteins and nucleic acids) for cell-to-cell
cross-talk by their inherent potencies, they have been expected as bio-
shuttles for efficient delivery of biomolecules inside the cells, especially
in the field of gene therapy [3]. Indeed, it was previously reported that
small interfering RNA (siRNA) was incorporated into exosomes by
electroporation and the siRNA tagged-exosomes were employed as a
delivery vector to decrease the target protein expression [4]. Exosomes
are also involved in the pathology of various diseases such as cancer,
cardiovascular diseases, and Alzheimer's diseases [5–7]. In particular,
in the field of cancer, cancer cell-derived exosomes have been men-
tioned to not only participate in the formation of the tumor micro-
environment and metastasis [8], but also possess tumor antigens that
are expected to be used in cancer immunotherapy [9]. Thus, exosomes
are expected as tools for treating diseases, and mechanisms of their
production and secretion are recognized as targets for development of
new therapies.
In order to obtain exosomes for research, laboratories generally use
conditioned medium from cultivated cells, relying on stepwise ultra-
centrifugation procedures. However, low yield and purity of exosomes
have been frequently observed [10]. The functions, properties, and
production amounts of EVs including exosomes have been reported to
be different between donor cells of EVs. For instance, mesenchymal
stem cells (MSCs) were reported to secrete more than 100-1000 fold
EVs compared with other cell lines such as myoblasts [11]. Other re-
searcher also reported that protein amount and EV particle number are
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different between certain cell lines [12]. Thus, for elucidation of spe-
cific functions of EVs and use of their functions, low yield of EVs from
donor cells can be an obstacle. In fact, it was previously reported that
the dose of injected EVs into mice varied from 1 to 150 μg in the case of
EVs been used as vehicles for drug delivery in some reports [13–15]. To
collect 150 μg of EVs from cultured cells, several number of dishes or
flasks are required. Therefore, obtaining higher yield of EVs from var-
ious cells can be advantage for progression of EV research. To increase
their yield and purity, polymeric precipitation and affinity-based pur-
ification methods have been reported [10,16]. In addition to these
methods, development of methods to increase exosome secretion from
cells would be a useful approach for increasing exosome yield. Several
mechanisms regarding the production and secretion of exosomes were
previously reported, including plasma membrane depolarization of
neurons [17], increases of intracellular Ca2+ concentrations being
trigger in certain cells [18], involvement of the Rab GTPase family [19],
and so on. Based on these findings, it is expected that activation of
intracellular signaling via stimulation of cultured cells may increase
exosome yield.
Our previous studies reported that low level electric treatment (ET;
0.3–0.5 mA/cm2), which is employed for iontophoresis, a transdermal
drug delivery technology, of cultured cells induce cellular uptake of
macromolecules such as small interfering RNA (siRNA) and dextran
(molecular weight: 10,000 and 70,000) via induction of endocytosis
[20,21]. With regard to the mechanisms of ET-mediated endocytosis,
we also reported that activation of Rho GTPase via heat shock protein
90 (HSP90) and protein kinase C (PKC) is involved in endocytosis in-
duction [22]. On the other hand, it was previously reported that early
endosomes imported by endocytosis are sort to late endosomes and then
form multivesicular bodies (MVB), and exosomes are produced in MVB
[23]. Then, exosomes are released after exocytic fusion of the MVB with
the plasma membrane via several signaling pathways [24]. Based on
these findings, we hypothesized that since ET of cultured cells activate
intracellular signaling and induce endocytosis, secretion of EVs in-
cluding exosomes from cultured cells would also be induced via ET. In
addition, if ET can increase EV secretion from cultivated cells, eluci-
dation of underlying mechanisms of ET-mediated increase of EV se-
cretion may lead to explore new therapeutic targets for certain diseases
by regulating EV secretion as well as development of a mean to increase
EV yield from the cells.
Therefore, in the present study, we investigated the effect of ET
(0.34 mA/cm2) on EV secretion, including exosomes, from cultured
cells by evaluating the number of particles and the amount of protein in
EVs harvested from conditioned medium. For this purpose, we used
B16F1 murine melanoma and 3T3 Swiss Albino cells as representative
cancer and normal cell line, respectively. The expression of re-
presentative exosome markers was also examined to confirm the quality
of the EVs collected following ET.
2. Materials and methods
2.1. Cell cultures
A murine melanoma cell line, B16F1, was purchased from DS
Pharma Biomedical Co., Ltd (Osaka, Japan). A murine fibroblast cell
line, 3T3 Swiss Albino, was obtained from RIKEN Cell Bank (Tsukuba,
Japan). B16F1 and 3T3 Swiss Albino cells were cultured in Dulbecco's
modified Eagle medium (DMEM; Nacalai Tesque, Kyoto, Japan) sup-
plemented with 10% fetal bovine serum (FBS), 100 U/mL penicillin
(Gibco, MA, USA), and 100 μg/mL streptomycin (Gibco). The cells were
cultured at 37 °C in a 5% CO2 incubator.
2.2. Collection of extracellular vesicles (EVs)
B16F1 or 3T3 Swiss Albino cells were seeded onto 150-mm dishes at
a density of 4 or 6 × 106 cells/dish, respectively, to reach
approximately 80% confluency after overnight incubation. Then, the
medium was removed, and the cells were washed with phosphate-
buffered saline (PBS). Cell culture medium was replaced with Advanced
DMEM (Gibco), a FBS and exosome-free medium, supplemented with
2 mM L-glutamine (Gibco), 100 U/mL penicillin, and 100 μg/mL
streptomycin. When performing ET, Ag–AgCl electrodes with 2.5 cm2
surface areas (3 M Health Care, Minneapolis, MN, USA) were placed in
the culture dish, and the cells were treated with a constant current of
0.34 mA/cm2 for 60 min. After 24 h of additional incubation, the
conditioned medium was collected, and EVs in the medium were pur-
ified as described previously [25]. In brief, the medium was subjected
to sequential centrifugation at 300×g for 10 min, 2000×g for 20 min,
and 10,000×g for 30 min at 4 °C, followed by filtration with 0.22-μm
syringe filters (Merck Millipore, MA, USA). Then, the samples were
ultracentrifuged at 100,000×g for 70 min at 4 °C (Optima L-90K;
Beckman Coulter, Tokyo, Japan) to pellet the EVs. The EVs were then
resuspended in PBS and subjected to ultracentrifugation (100,000×g,
70 min, 4 °C) for washing. The resultant EVs were resuspended in PBS
and used in the following experiments. Also, after harvesting the con-
ditioned medium, the cells were trypsinized and the number of the cells
was determined by trypan blue staining.
2.3. Measurement of EV particle size distribution, particle number and ζ-
potential
The particle size distribution and the number of particles in the
collected EV suspension were measured with a nanoparticle multi-
analyzer (qNano; Meiwafosis Co., Ltd., Tokyo, Japan). To determine the
ζ-potential of the EVs, a Zetasizer Nano ZS (Malvern Instruments,
Worcestershire, UK) was employed.
2.4. Transmission electron microscopy
To observe the morphology of the collected EVs by transmission
electron microscopy (TEM), the samples were absorbed to formvar film
coated copper grids and were negatively stained with 2% phospho
tungstic acid solution (pH 7.0) for 60 s. Then, the grids were observed
by a transmission electron microscope (JEM-1400Plus; JEOL Ltd.,
Tokyo, Japan) at an acceleration voltage of 100 kV. Digital images were
taken with a CCD camera (EM-14830RUBY2; JEOL Ltd.).
2.5. Quantification of protein amount of EVs
The protein concentration of the collected EVs was determined by
using a Micro bicinchoninic acid (BCA) Protein Assay Kit (Pierce
Biotechnology, Rockford, IL, USA) according to the manufacturer's in-
structions. The absorbance of each sample at 562 nm was measured
with a Tecan Infinite M200 microplate reader (Salzburg, Austria).
2.6. Western blotting
Anti-CD9 rabbit monoclonal antibody (ab92726; Abcam,
Cambridge, UK), anti-HSP70 mouse monoclonal antibody (ab5439;
Abcam), anti-CD81 mouse monoclonal antibody (sc-166029; Santa Cruz
Biotechnology, CA, USA), horse-radish peroxidase (HRP)-conjugated
anti-rabbit IgG polyclonal antibody (A24531; Thermo Fisher Scientific,
Waltham, MA, USA), and HRP-conjugated anti-mouse IgG rabbit poly-
clonal antibody (ab97046; Abcam) were purchased as indicated. To
observe the expression of CD9, HSP70, and CD81 in the collected EVs,
the EVs (1 μg protein) were subjected to 10% (for CD9 and HSP70) or
12.5% (for CD81) SDS-PAGE, and the proteins were electrophoretically
transferred to a polyvinylidene difluoride (PVDF) membrane (Bio-Rad,
Hercules, CA, USA). The PVDF membrane was incubated with 3% bo-
vine serum albumin (BSA) dissolved in Tris-HCl-buffered saline con-
taining 0.1% Tween20 (pH 7.4) for 1 h at 37 °C, then with anti-CD9
antibody (1:2000), anti-HSP70 antibody (1:2000), or anti-CD81
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antibody (1:100) for 24 h at 4 °C, respectively. Thereafter, the mem-
brane was incubated with each secondary antibody at a dilution of
1:2000 for rabbit IgG or 1:5000 for mouse IgG for 1 h at 37 °C. After
incubation of the membrane with a chemiluminescent substrate reagent
(ECL prime; GE Healthcare, Little Chalfont, UK), the bands of each
protein were detected with a LAS-4000 mini system (Fuji Film, Tokyo,
Japan).
2.7. Rho GTPase inhibition experiment with pharmacological inhibitor
For mechanistic study, B16F1 or 3T3 Swiss Albino cells were seeded
onto 150-mm dishes at a density of 4 or 6 × 106 cells/dish, respec-
tively. After washing the cells with PBS followed by replacing with
Advanced DMEM supplemented with 2 mM L-glutamine, 100 U/mL
penicillin, and 100 μg/mL streptomycin, a Rho GTPase inhibitor Rhosin
hydrochloride (Tocris Bioscience, Bristol, UK) dissolved in dimethyl
sulfoxide (DMSO; Wako Pure Chemical, Osaka, Japan) was added into
the culture media to become a concentration of 10 or 30 μM. The final
concentration of DMSO in the media was 0.1% in each group. Then, the
cells were treated with a constant current of 0.34 mA/cm2 for 60 min in
the presence or absence of the Rho GTPase inhibitor. After 24 h of
additional incubation, the conditioned medium was collected, and EVs
in the medium were purified as mentioned above. Thereafter, the
number of particles in the collected EV suspension was measured with
the nanoparticle multi-analyzer qNano.
2.8. Evaluation of EV uptake
For uptake study, the EVs collected from B16F1 and 3T3 Swiss
Albino cells were collected with or without ET as described above,
followed by fluorescence-labeling with PKH67 (Sigma-Aldrich, MO,
USA) according to the manufacturer's protocol. The PKH67-labeled EVs
were washed twice with PBS by using Amicon Ultra 10K (Merck
Millipore). B16F1 and 3T3 Swiss Albino cells were seeded onto a 35-
mm glass bottom dish at a density of 1 × 105 cells/dish. After 24-h
incubation, PKH67-labeled EVs derived from B16F1 or 3T3 Swiss
Albino were added to B16F1 or 3T3 Swiss Albino cells, respectively, to a
final concentration of 5 μg protein/mL in serum free DMEM. After 6-h
incubation, the media were removed and the cells were washed twice
with PBS. Then, the cells were fixed with 4% paraformaldehyde for
20 min at 37 °C. After washing the cells with PBS three times, the cells
were incubated with 1 μg/mL 4′, 6-diamidino-2-phenylindole (DAPI;
Thermo Fisher Scientific) in PBS for 15 min at 37 °C to stain nuclei.
After washing with PBS, the fluorescence was observed using a confocal
laser scanning microscope (LSM700, Carl Zeiss). To evaluate relative
uptake amount of each PKH-labeled EVs, fluorescence intensities of
PKH67 were analyzed for 12 images per each group for one experiment
using an image-analysis system Image J. The experiments were per-
formed 3 times independently.
2.9. Statistical analysis
The statistical differences were evaluated by one-way analysis of
variance with the Tukey post-hoc test. Those in 2 groups were de-
termined by using Student's t-test. Data were presented as the
mean ± S.D.
3. Results
3.1. Physicochemical properties of collected EVs
By using B16F1 and 3T3 Swiss Albino as representative cancer and
normal cell lines, we examined the influence of ET (0.34 mA/cm2) on
EV secretion. ET onto the cultured cells was performed as shown in
Fig. 1. First, we examined physicochemical properties of EVs collected
by ultracentrifugation from the culture supernatants. As shown in
Table 1, the average particle sizes of the collected EVs ranged from
approximately 100 to 120 nm in diameter, and their ζ-potentials were
approximately −20 to −25 mV. The statistically significant differences
in the particle size and the ζ-potential were not found between EVs
collected from each cell exposed or not exposed to ET. Histograms of
the particle size distribution obtained with a nanoparticle multi-ana-
lyzer indicated that the collected EVs from both cell lines showed si-
milar distribution patterns regardless of the treatment with low level
electricity (Figs. 2A–D). We also performed TEM observations to vi-
sualize the isolated EVs. The TEM images showed globular vesicles
having approximately 100 nm in diameter in each EV sample
(Figs. 2E–H). Moreover, the particle size of the EVs from B16F1 tended
to be smaller than those from 3T3 Swiss Albino in agreement with the
results of Table 1.
3.2. ET increased EV secretion from cultured cells
Next, we investigated the effect of ET on EV secretion from cultured
cells by determining particle number and protein amount. The results
showed that ET increased the particle number of EVs from both B16F1
(1.26-fold) and 3T3 Swiss albino (1.7-fold) cells (Figs. 3A and B). In
particular, the number of EVs in the size (diameter) range 90–130 nm
was markedly increased as shown in the particle distribution data
(Figs. 3C and D). We also analyzed the particle distribution of EVs
collected without the procedure of filtration using 0.22-μm syringe
filter. The results showed that ET-mediated increase of the number of
EVs having over 150 nm was not remarkable compared with that of less
than 150 nm in both cell lines (Supplementary Fig. 1). The amount of
protein in the collected EVs was significantly higher in the group
treated with low level electricity compared with the non-treated group,
and this tendency was observed with both B16F1 (1.6-fold) and 3T3
Swiss albino (1.25-fold) cell lines (Figs. 4A and B). On the other hand,
Fig. 1. Graphic illustration of ET onto the cultured cells. For the treatment of
the cultured cells with low level electricity, two Ag–AgCl electrodes with
2.5 cm2 surface areas were placed in the culture dish. Then, the cells were
treated with a constant current of 0.34 mA/cm2 for 60 min. Twenty-four hours
after ET, the conditioned medium was collected, and extracellular vesicle (EV)
isolation was performed by the ultracentrifugation procedures.
Table 1
Particle sizes and ζ-potentials of the EVs harvested from each cell line.
Exosome-producing cells Particle size (d.nm) ζ-Potential (mV)
B16F1 (ET (−)) 105.5 ± 8.5 −26.1 ± 2.7
B16F1 (ET (+)) 108.0 ± 9.8 −26.2 ± 8.4
3T3 Swiss Albino (ET (−)) 111.3 ± 8.2 −18.6 ± 7.2
3T3 Swiss Albino (ET (+)) 118.2 ± 12.4 −20.0 ± 5.0
The data indicate the mean ± S.D. (n = 5).
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the protein contents of the cells were comparable between non-treated
cells and low level electricity-treated cells at 24 h after ET
(Supplementary Fig. 2). The number of viable cells 24 h after 1 h of ET
was also evaluated for each cell line. There was almost no difference in
cell viability between the groups treated with low level electricity and
the non-treated group in both cell lines (Figs. 4C and D). By changing
the current strength and time of ET, we evaluated the increase of EV
secretion in B16F1 cells by BCA assay. When ET (0.34 or 0.5 mA/cm2)
was performed for 15 min, the protein amount of EVs tended to increase
compared with non-treated group (Supplementary Fig. 3A). Treatment-
time dependent increase in the protein amounts of the collected EVs
was observed, and the amounts were significantly increased in the
groups of ET with a constant current of 0.34 or 0.5 mA/cm2 for 60 min.
On the other hand, significant decrease in cell viability determined
based on the cell number after 24 h of ET was observed in the cells
exposed to ET (0.5 mA/cm2) for 60 min (Supplementary Fig. 3B).
Considering the balance between increase of protein amounts and cell
viability, ET (0.34 mA/cm2) for 60 min was suggested to be best among
the examined conditions, and the condition was used in the following
experiments.
3.3. Influence of ET on the expression of representative exosomal marker
proteins
To assess the influence of ET on the quality of the collected EVs,
expression of representative exosomal markers, namely CD9, HSP70,
and CD81, in the EVs was confirmed by Western blotting. Western
blotting showed that each exosome marker was present in the EVs
derived from each cell line regardless of the treatment with low level
electricity, although the expression of HSP70 was quite low in 3T3
Swiss Albino-derived EVs (Figs. 5A and B), as reported previously [12].
These results suggest that ET could increase the secretion of EVs from
both cancer and normal cells without changes in expression of re-
presentative exosomal markers. In addition, the ratios of particle
numbers to the amounts of protein were calculated based on the results
of Fig. 3A, B, 4A, and 4B. Although particle number/protein quantity
tended to increase by ET in 3T3 Swiss Albino cells, significant differ-
ences were not observed in either cell line regardless of the treatment
by low level electricity (Figs. 5C and D), suggesting that the increased
EV protein amount is due to the increased number of secreted EVs.
Based on these results, it was suggested that ET did not change the
quality of the secreted EVs from either cancer or normal cells.
Fig. 2. Particle distribution and morphology of the EVs collected from culture
cells. B16F1 and 3T3 Swiss Albino cells were treated by low level electricity
(ET; 0.34 mA/cm2) for 1 h. After 24 h of incubation, EVs were collected from
the conditioned medium of each cell line by ultracentrifugation. Then, the
particle distributions of the EVs collected from B16F1 ((A): ET (−), (B): ET
(+)) and 3T3 Swiss Albino ((C): ET (−), (D) ET (+)) were analyzed with a
qNano. The morphologies of the EVs collected from B16F1 ((E): ET (−), (F): ET
(+)) and 3T3 Swiss Albino ((G): ET (−), (H): ET (+)) were observed by TEM.
Scale bars = 100 nm.
Fig. 3. Enhancement of EV secretion from cultivated cells by ET. The particle
number of the collected EVs from B16F1 (A) and 3T3 Swiss Albino (B) cells
treated with or without low level electricity (0.34 mA/cm2, 1 h) was de-
termined. The data show the mean ± S.D. (n = 5). *P < 0.05 vs. ET (−). The
representative graphs of the particle concentration curve were obtained from
B16F1- (C) and Swiss 3T3 Albino-derived EVs (D).
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3.4. Influence of Rho GTPase inhibition on ET-mediated increase in EV
secretion
Since our previous study demonstrated that ET of cultured cells
induces endocytosis of macromolecules via activation of Rho GTPase
[22], we evaluated the influence of Rho GTPase inhibition on ET-
mediated increase in EV secretion by using a Rho GTPase inhibitor,
Rhosin hydrochloride [26]. The results showed that increase in the
particle number of the collected EVs from 3T3 Swiss Albino cells treated
by low level electricity was hardly inhibited by the Rho GTPase in-
hibitor (Fig. 6B). On the other hand, the number of particles was de-
creased in the Rho GTPase inhibitor dose-dependent manner in the EVs
collected from B16F1 exposed to ET (Fig. 6A). Notably, significant
decrease in the particle number was observed in B16F1 cells treated
with 30 μM of the inhibitor. These results suggest that Rho GTPase
activation could be involved in ET-mediated increase in EV secretion in
a cancer cell B16F1.
3.5. Cellular uptake of EVs collected from each cell exposed to ET
To evaluate whether ET affects functionalities of the collected EVs,
cellular uptake of the EVs collected with or without ET into each donor
cell was observed by fluorescence labeling of EVs with PKH67. Confocal
images showed that PKH-labeled EVs derived from B16F1 cells tended
to similarly be uptaken into B16F1 (donor) cells regardless of whether
the EVs had been collected after ET of the cells (Figs. 7A and B). The
quantitative data of relative fluorescence intensity indicated that up-
take amounts of EVs into B16F1 cells were comparable between EVs
collected with or without ET (Fig. 7C). The EVs derived from 3T3 Swiss
Albino cells exposed to ET were similarly uptaken into 3T3 Swiss Albino
cells in comparison to those derived from the cells without ET (Fig. 7D
and E). Their uptake amounts into 3T3 Swiss Albino cells were also
comparable between EVs harvested with or without ET (Fig. 7F). Based
on the results of EV uptake study, it was suggested that ET would not
affect the apparent functionality of the secreted EVs.
4. Discussion
It was previously reported that exosomes produced in MVB were
released from cells after MVB fusion with the cellular membrane, a
process depending upon several intracellular signaling pathways [23].
Thus, external stimuli that activate intracellular signaling would likely
increase exosome secretion from the cells. Our previous reports de-
monstrated that treatment of cultivated cells with ET (0.34 mA/cm2)
activates intracellular signaling and induces endocytosis of extraneous
Fig. 4. ET increased the amount of protein in the collected EVs. The quantity of
protein in the EVs harvested from the conditioned medium of B16F1 (A) and
3T3 Swiss Albino (B) was measured by BCA assay. The number of cells was
counted by trypan blue staining after collecting their conditioned media. The
relative percentage of viability to that of non-treated cells is indicated (C:
B16F1, D: 3T3 Swiss Albino). The data show the mean ± S.D. (n = 5).
*P < 0.05, **P < 0.01 vs. ET (−).
Fig. 5. Western blot analysis of the expression of the exosomal marker proteins.
EVs derived from B16F1 (A) and 3T3 Swiss Albino (B) were subjected to SDS-
PAGE (1 μg/lane). Western blotting was performed to observe the expression of
exosome markers CD9, HSP70, and CD81. Per the product datasheet, the de-
tected molecular weights of CD9, HSP70, and CD81 are approximately 25,
70–78, and 22–26 kDa, respectively. The experiments were performed 3 times
independently. The ratios of particle number per protein amount of the EVs
collected from B16F1 (C) and 3T3 Swiss Albino (D) were calculated based on
the results of Fig. 2 and 3.
Fig. 6. Effect of Rho GTPase inhibition on increase in EV secretion by ET.
B16F1 and 3T3 Swiss Albino cells were exposed to ET (0.34 mA/cm2) for 1 h in
the presence of Rho GTPase inhibitor at the indicated concentration. After 24 h
of additional incubation, EVs were collected, and the particle number of the
collected EVs from B16F1 (A) and 3T3 Swiss Albino (B) cells was then measured
with a qNano. The relative particle number of each group to that in control (ET
(−)) are presented. The data show the mean ± S.D. (n = 4). Significant
difference; *P < 0.05.
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macromolecules such as siRNA and FITC-conjugated dextran (mole-
cular weight: 10,000 and 70,000) [20–22]. Hence, in this study, we
investigated whether ET-mediated intracellular signaling activation
leads to increased EV secretion from cultured cells. Towards that end,
we used murine melanoma B16F1 and murine fibroblast 3T3 Swiss
Albino cells as a representative cancer cell line and a normal cell line,
respectively.
The analysis of the physicochemical properties showed that the
average particle size, ζ-potential, particle distribution, and morphology
of EVs collected from cells exposed to ET were comparable with those
collected from non-treated cells (Fig. 2 and Table 1). On the other hand,
the number of secreted EVs was increased in the group treated by low
level electricity (Figs. 3A and B). Notably, the particle distribution
analysis showed that EVs approximately 90–130 nm in diameter pro-
minently increased by ET (Figs. 3C and D). As shown in Supplementary
Fig. 1, in case of the particle distribution of EVs collected without the
procedure of filtration using 0.22-μm syringe filter been analyzed, ET-
mediated increase of the number of EVs having over 150 nm was not
remarkable compared with that of less than 150 nm. Regarding the
definition of EVs, it was previously reported that particles with dia-
meters in the 40–150 nm range were defined as exosomes and those
with diameters of 100-1000 nm were microvesicles [1,27]. Based on
our results and previous reports, it is suggested that secretion of exo-
somes would be increased by ET, although microvesicles having ap-
proximately 100 nm could also be contained. In addition to particle
number, ET significantly increased the protein amounts of harvested
EVs from B16F1 and 3T3 Swiss Albino cells without remarkable cellular
toxicity (Fig. 4). The results also suggest that EV secretion from cultured
cells was promoted by ET. A slight decrease of cell viability was ob-
served in the cells exposed to ET as shown in Figs. 4C and D. Our
previous study demonstrated that ET induces the dissociation of in-
tracellular junctions via cell signaling activation accompanying with
filamentous-actin (F-actin) depolymerization [28]. After ET of the cells,
their slight detachment from the dish was seen, whereas the growth rate
of the cells was not changed even at 48 h after ET between the cells
exposed to or not exposed to ET (data not shown). It is speculated that
the ET-mediated F-actin depolymerization may cause slight detachment
of the cells, resulting in slight decrease in cell viability determined
based on the cell number at 24 h after ET. The results of Western
blotting showed that the expression of representative exosomal marker
proteins, namely CD9, HSP70, and CD81, was hardly changed in
comparisons of cells exposed to ET vs. non-treated cells (Figs. 5A and
B). Moreover, the ratios of particle numbers to protein amounts were
not significantly changed by ET in either cell line (Figs. 5C and D),
indicating that the quality of the collected EVs seems to be unaltered by
ET.
Since the expression of representative exosomal marker proteins
was almost not changed by ET, we next investigated the functionality of
EVs collected from the cells exposed to ET by evaluating uptake of the
EVs derived from B16F1 and 3T3 Swiss Albino cells into each donor
cell, respectively. As shown in Fig. 7, there were almost no differences
in uptake of each EV into each donor cell regardless of whether the cells
had been exposed to ET for EV collection. In addition, the ζ-potential of
each EV was not changed by ET as shown in Table 1. These results
indicate that ET could not influence at least surface properties of the
lipid membranes of the secreted EVs, which led to almost no change in
the uptake of each EV into the donor cells. However, since certain
conditions (e.g. hypoxia) and stimuli were reported to alter components
of lipids in EV membranes and nucleic acids [29–31], there is a possi-
bility that ET also changes the components of lipid membranes and
nucleic acid contents in the secreted EVs. Although the uptake of the
EVs derived from the cells exposed to ET did not apparently change in
comparison with the EVs derived from non-treated cells, further de-
tailed studies to reveal changes in the components of lipid membranes
and nucleic acid contents in EVs are needed in future.
Other researchers previously reported that several stimuli, such as
acidic pH [32,33], hypoxic condition [29], exposure to anticancer drugs
[34], and treatment with liposomes of certain lipid compositions [35],
can increase EV secretion from cancer cells. However, acidic pH, hy-
poxic conditions and anticancer drug treatment alter the lipid compo-
sition of EV membranes and the contents in the exosomes, resulting in a
change of the quality of the EVs compared with those collected under
normal conditions. Regarding the method by using liposomes, there is a
need to exhaustively separate EVs and liposomes to achieve high purity.
As other modality to increase EV secretion, low-level laser irradiation
(LLLI) was also previously reported [36]. LLLI at a power intensity of
80 J/cm2 could increase EV biogenesis via induction of autophagy and
transcription factors which promote Wnt signaling pathways and
GTPase activity in human endothelial cells, although the power in-
tensity was cytotoxic dose. Based upon the expression of exosomal
marker proteins and the ratio of particle number to protein amount, our
current results demonstrated that ET can easily increase EV secretion
from cultured cells without apparent cellular toxicity or changes in
exosome quality. In addition, ET could increase EV secretion from not
only a cancer cell (B16F1) but also a normal cell (3T3 Swiss Albino),
implying that the method using ET may be applied for various types of
cells, whereas other stimuli reported previously were investigated only
Fig. 7. Cellular uptake of EVs collected with or without exposure of the cells to
ET. B16F1 and 3T3 Swiss Albino cells (1 × 105 cells/35-mm dish) were in-
cubated with PKH67-labeled EVs (5 μg protein/mL) derived from B16F1 and
3T3 Swiss Albino cells, respectively, for 6 h at 37 °C. Then, the cells were fixed,
and their nuclei were counterstained with DAPI. Fluorescence images of B16F1
(A and B) and 3T3 Swiss Albino (D and E) were obtained by confocal laser
scanning microscopy. Blue and green colors show the fluorescence of DAPI
(nuclei) and PKH67 (EVs), respectively. The images of right columns are
merged images of those of DAPI, PKH67, and phase contrast. Scale
bars = 50 μm. The relative fluorescence intensities of EVs (ET (+)) to that of
EV (ET (−)) was calculated from 12 images per each group of B16F1 (C) and
3T3 Swiss Albino cells (F) for one experiment by using Image J. The experi-
ments were performed three times independently. The data show the
mean ± S.D. (n = 3).
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in cancer cell lines except that the method using LLLI was performed in
human ECs. Although the detailed mechanisms of ET-mediated EV se-
cretion need to be elucidated, our previous studies reported that ET
induces Rho GTPase activation via HSP90 and PKC by Ca2+ influx, and
also phosphorylates Ras-related protein Rab-10, a protein associated
with vesicle-mediated transport processes [22]. Since cellular signal-
ings including Rho GTPase [37], the Rab family [19], and increase of
intracellular Ca2+ were reportedly involved in the production and se-
cretion of exosomes [18], ET-mediated activation of those signaling
pathways could increase EV secretion. In fact, in the present study, Rho
GTPase inhibition significantly suppressed the ET-mediated increase of
EV secretion in a dose-dependent manner in B16F1 (Fig. 6), implying
that Rho GTPase activation could be involved in ET-mediated EV se-
cretion in a cancer cell B16F1. On the other hand, the ET-mediated
increase in the particle number of the EVs was hardly inhibited in the
presence of the Rho GTPase inhibitor in 3T3 Swiss Albino cells. Re-
garding the reason why the effect of Rho GTPase inhibition was dif-
ferent between B16F1 and 3T3 Swiss Albino cells, it is speculated that
sensitivity to the Rho GTPase inhibitor might be different between the
cell species. To clarify the mechanism of ET-mediated increase in EV
secretion, further detailed studies are needed in future. The pathways of
exosome production and secretion have recently been analyzed as novel
therapeutic targets for various diseases [5–7,38,39]. For instance, it was
previously reported that sera from type 2 diabetic patients disturb the
normal exosome signaling in human mesenchymal stem cells (hMSCs),
and that the diabetic condition could decrease angiogenic potential and
restorative effects of hMSCs [40,41]. Based on these findings, elucida-
tion of the central role of the activated exosome secretion pathway has
been needed to predict the behavior of hMSCs under diabetic condition.
Thus, to clarify the mechanisms of EV secretion by ET may lead to
explore new therapeutic targets as well as development of methods to
increase EV yield from cultured cells. In addition, there is a possibility
that ET can be applied for a tool to elucidate mechanisms involved in
EV secretion, including Rho GTPase focused in the present study, in
certain types of the cells.
In clinical area, transcranial direct current stimulation (tDCS), a
non-invasive brain stimulation procedure by the treatment of brain
through the skull by low level electricity, has been shown effective for
alleviation of neuropsychiatric and neurological conditions such as
major depression, and also effective for enhancement of learning and
memory formation in humans [42]. However, detailed cellular me-
chanisms for positive effects by ET onto brain remain largely unclear.
Our previous and present studies demonstrated that ET induces acti-
vation of intercellular signaling such as Rho GTPase via HSP90 and PKC
[22], and also increases the secretion of EV from cultured cells. Al-
though the effect of ET on brain-derived cells are needed to be ex-
amined in future, ET-mediated intracellular signaling activation and
increase of EV secretion may have the potential to be involved in
beneficial effects of tDCS in the brain.
In conclusion, the present study demonstrated that low level ET of
cultured cells markedly increased both particle number and protein
amount of the resultant EVs. This was observed in murine melanoma
B16F1 and murine fibroblast 3T3 Swiss Albino cells without obvious
cellular toxicity or a change in the ratio of particle number to protein
quantity. Moreover, the expression of representative exosome markers,
namely CD9, HSP70, and CD81, was comparable between the cells re-
gardless of ET. As a mechanism, Rho GTPase inhibition significantly
suppressed ET-mediated increase of EV secretion in B16F1, suggesting
that Rho GTPase activation could be involved in ET-mediated EV se-
cretion in the cell. Additionally, there were almost no differences in
uptake of each EV into donor cells used in this study regardless of
whether the cells had been exposed to ET for EV collection. Thus, ET
could be used as a method to increase the yield of EVs from both cancer
and normal cells.
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